Related references
Note: Only part of the references are listed.No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy
N. Bernards et al.
ANNALS OF ONCOLOGY (2013)
Characteristics, therapy and outcome in an unselected and prospectively registered cohort of pancreatic cancer patients
J. K. Bjerregaard et al.
EUROPEAN JOURNAL OF CANCER (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Well, I Think There Is Great Variation...: A Qualitative Study of Oncologists' Experiences and Views Regarding Medical Criteria and Other Factors Relevant to Treatment Decisions in Advanced Cancer
Jan Schildmann et al.
ONCOLOGIST (2013)
Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality
R. F. de Wilde et al.
BRITISH JOURNAL OF SURGERY (2012)
415 Patients with Adenosquamous Carcinoma of the Pancreas: A Population-Based Analysis of Prognosis and Survival
Casey A. Boyd et al.
JOURNAL OF SURGICAL RESEARCH (2012)
Improving outcome for patients with pancreatic cancer through centralization
V. E. P. P. Lemmens et al.
BRITISH JOURNAL OF SURGERY (2011)
FOLFIRINOX: A Small Step or a Great Leap Forward?
Andrew H. Ko
JOURNAL OF CLINICAL ONCOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Are Patients of Low Socioeconomic Status Receiving Suboptimal Management for Pancreatic Adenocarcinoma?
Michael C. Cheung et al.
CANCER (2010)
A visual summary of the EUROCARE-4 results: a UK perspective
H. Moller et al.
BRITISH JOURNAL OF CANCER (2009)
The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis
Roberta De Angelis et al.
EUROPEAN JOURNAL OF CANCER (2009)
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer
Asma Sultana et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Trends in the treatment and outcome of pancreatic cancer in the United States
Nancy N. Baxter et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Survival among patients with adenocarcinoma of the pancreas: A population-based study (United States)
RD Cress et al.
CANCER CAUSES & CONTROL (2006)
Treatment of locally advanced pancreatic cancer in the real world: Population-based practices and effectiveness
MK Krzyzanowska et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer:: a randomised controlled trial
JP Neoptolemos et al.
LANCET (2001)
Share Paper
